IP Library › Patent Application 62806705
Patent Application Provisional
App. No. 62/806,705 · Confirmation No. 4381

Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile

Applicant: Novartis AG
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2021-01-27 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2021-01-27 APP.FILE.REC Filing Receipt 3 View
2021-01-25 R48.REQ Request under Rule 48 correcting inventorship 3 View
2021-01-25 ADS Application Data Sheet 10 View
2021-01-25 WFEE Fee Worksheet (SB06) 2 View
2021-01-25 N417 Electronic Filing System Acknowledgment Receipt 2 View
2019-05-22 APP.FILE.REC Filing Receipt 3 View
2019-05-16 APP.FILE.REC Filing Receipt 3 View
2019-05-16 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2019-05-14 CFILE Request for Corrected Filing Receipt 2 View
2019-05-14 ADS Application Data Sheet 10 View
2019-05-14 WFEE Fee Worksheet (SB06) 2 View
2019-05-14 N417 Electronic Filing System Acknowledgment Receipt 2 View
2019-02-27 APP.FILE.REC Filing Receipt 3 View
2019-02-15 ADS Application Data Sheet 9 View
2019-02-15 DRW Drawings-only black and white line drawings 10 View
2019-02-15 ABST Abstract 1 View
2019-02-15 CLM Claims 15 View
2019-02-15 SPEC Specification 85 View
2019-02-15 WFEE Fee Worksheet (SB06) 2 View
2019-02-15 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/806,705
Filed
2019-02-15